|
Central serous choroidopathy (CSCR) is an eye
disorder that is found most commonly in
young men, 20 to 50 years of age.
Symptoms
Symptoms usually include a rather sudden
onset of blurred vision in one eye,
minification of images, reduced color
vision, or a central "blind spot" in the
involved eye.
Causes
The exact cause of the condition is unknown,
but the disorder is characterized by
"leakage" of fluid in the central
macula
(see illustration). Patients with CSCR generally have
vision in the 20/20 to 20/100 range and a
serous (clear fluid) retinal detachment may
be discovered by the examining
ophthalmologist. A
fluorescein angiogram may
be used to confirm the diagnosis.
Type A personalities and systemic
hypertension may be associated with CSCR.
Prognosis
Patients diagnosed with CSCR generally have a
good prognosis for recovery of vision,
though the condition may take six months or
more to resolve. Recurrence of leakage is
quite common.
Treatment
Laser photocoagulation (treatment) to the
retina may speed recovery of vision, but
does not result in better final
visual
acuity. Laser photocoagulation itself has
potential risks, which require careful
consideration. Most patients are followed
every two months until the condition
spontaneously improves. If significant
visual loss persists beyond 4-6 months,
laser treatment may again be considered.
Steroid eye drops may be prescribed to
reduce the inflammation caused by leakage. |
